A phase 1 study of healthy subjects and patients with rheumatoid arthritis receiving single doses of SAN-300 or placebo to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of SAN-300.
Phase of Trial: Phase I
Latest Information Update: 08 Jun 2016
At a glance
- Drugs SAN 300 (Primary) ; SAN 300 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Santarus
- 28 Oct 2013 Results presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.
- 28 Oct 2013 Results were presented at the Annual Meeting of the American College of Rheumatology (ACR-2013)
- 05 Mar 2013 Status changed from active, no longer recruiting to completed, according to a Santarus media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History